Citations (68)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
NinaA. Cooperman, Moonseong Heo, KarinaM. Berg, Xuan Li, AlainH. Litwin, Shadi Nahvi & JuliaH. Arnsten. (2012) Impact of adherence counseling dose on antiretroviral adherence and HIV viral load among HIV-infected methadone maintained drug users. AIDS Care 24:7, pages 828-835.
Read now
Read now
PhoenixK.H. Mo & WinnieW.S. Mak. (2009) Intentionality of medication non-adherence among individuals living with HIV/AIDS in Hong Kong. AIDS Care 21:6, pages 785-795.
Read now
Read now
DorieJ. Gilbert, Elizabeth Abel, Nancy
Francisco Stewart & Margarita Zilberman. (2007) More Than Drugs. Journal of HIV/AIDS & Social Services 6:1-2, pages 161-179.
Read now
Read now
NinaA. Cooperman, JeffreyT. Parsons, Brenda Chabon, KarinaM. Berg & JuliaH. Arnsten. (2007) The Development and Feasibility of an Intervention to Improve HAART Adherence Among HIV-Positive Patients Receiving Primary Care in Methadone Clinics. Journal of HIV/AIDS & Social Services 6:1-2, pages 101-120.
Read now
Read now
Linda Weiss$suffix/text()$suffix/text(), Tyler French, Mark Waters, Julie Netherland, Bruce Agins & Ruth Finkelstein. (2006) Adherence to HAART: Perspectives from clients in treatment support programs. Psychology, Health & Medicine 11:2, pages 155-170.
Read now
Read now
T. Kerr, A. Marshall, J. Walsh, A. Palepu, M. Tyndall, J. Montaner, R. Hogg & E. Wood. (2005) Determinants of HAART discontinuation among injection drug users. AIDS Care 17:5, pages 539-549.
Read now
Read now
K. K. Uldall, N. B. Palmer, K. Whetten, C. Mellins & For The Hiv/aids Treatment Adherence, Health Outcomes And Cost Study Group. (2004) Adherence in people living with HIV/AIDS, mental illness, and chemical dependency: a review of the literature. AIDS Care 16:sup1, pages 71-96.
Read now
Read now
C. J. Reback, S. Larkins & S. Shoptaw. (2003) Methamphetamine abuse as a barrier to HIV medication adherence among gay and bisexual men. AIDS Care 15:6, pages 775-785.
Read now
Read now
Craig Demmer. (2001) Nonadherence to HIV Treatment: Implications for Health Educators. American Journal of Health Education 32:1, pages 16-25.
Read now
Read now
Sybil G. Hosek, Gary W. Harper & Rocco Domanico. (2000) Psychological and Social Difficulties of Adolescents Living With HIV: A Qualitative Analysis. Journal of Sex Education and Therapy 25:4, pages 269-276.
Read now
Read now
Articles from other publishers (58)
Saurabh Mishra, Sunil TanejaArka DeNipun VermaMadhumita PremkumarG.S.R.S.N.K. NaiduAman SharmaAjay DusejaRadha Krishan DhimanVirendra Singh. (2023) Efficacy, Tolerability, and Compliance of Direct Acting Antivirals in Patients with HIV and Hepatitis C Coinfection: A Real-Life Experience. AIDS Research and Human Retroviruses 39:9, pages 453-458.
Crossref
Crossref
Jenny Iversen, Salman ul Hasan Qureshi, Malika Zafar, Machteld Busz & Lisa Maher. (2021) Adherence to antiretroviral therapy among HIV positive men who inject drugs in Pakistan. International Journal of Drug Policy 96, pages 103281.
Crossref
Crossref
Lance Rintamaki, Kami Kosenko, Timothy Hogan, Allison M. Scott, Christopher Dobmeier, Erik Tingue & David Peek. (2019) The Role of Stigma Management in HIV Treatment Adherence. International Journal of Environmental Research and Public Health 16:24, pages 5003.
Crossref
Crossref
Jørn Henrik Vold, Christer Aas, Rafael Alexander Leiva, Peter Vickerman, Fatemeh Chalabianloo, Else-Marie Løberg, Kjell Arne Johansson & Lars Thore Fadnes. (2019) Integrated care of severe infectious diseases to people with substance use disorders; a systematic review. BMC Infectious Diseases 19:1.
Crossref
Crossref
Rafia S. Rasu, David F. Malewski, Julie W. Banderas, Domonique Malomo Thomson & Kathy Goggin. (2013) Cost of Behavioral Interventions Utilizing Electronic Drug Monitoring for Antiretroviral Therapy Adherence. JAIDS Journal of Acquired Immune Deficiency Syndromes 63:1, pages e1-e8.
Crossref
Crossref
Jeanette M. Tetrault, Brent A. Moore, Declan T. Barry, Patrick G. O'Connor, Richard Schottenfeld, David A. Fiellin & Lynn E. Fiellin. (2012) Brief versus extended counseling along with buprenorphine/naloxone for HIV-infected opioid dependent patients. Journal of Substance Abuse Treatment 43:4, pages 433-439.
Crossref
Crossref
Meredith Camp Binford, Shoshana Y. Kahana & Frederick L. Altice. (2012) A Systematic Review of Antiretroviral Adherence Interventions for HIV-Infected People Who Use Drugs. Current HIV/AIDS Reports 9:4, pages 287-312.
Crossref
Crossref
Hartmut B Krentz, Ian Cosman, Kathy Lee, Jinell Mah Ming & M John Gill. (2012) Pill Burden in HIV Infection: 20 Years of Experience. Antiviral Therapy 17:5, pages 833-840.
Crossref
Crossref
Marc Bourdeau, Philippe Delmas & Hélène Sylvain. (2012) Using partial components to restore and use the concurrent validity of the Index of Readiness. Tutorials in Quantitative Methods for Psychology 8:2, pages 70-87.
Crossref
Crossref
Michael A. Horberg, Leo B. Hurley, William J. Towner, Michael W. Allerton, Beth T. Tang, Sheryl L. Catz, Michael J. Silverberg & Charles P. Quesenberry. (2012) Determination of Optimized Multidisciplinary Care Team for Maximal Antiretroviral Therapy Adherence. JAIDS Journal of Acquired Immune Deficiency Syndromes 60:2, pages 183-190.
Crossref
Crossref
Pier Paolo Pani, Rosangela Vacca, Emanuela Trogu, Laura Amato & Marina Davoli. (2010) Pharmacological treatment for depression during opioid agonist treatment for opioid dependence. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Honghong Wang, Jun Zhou, Ling Huang, Xianhong Li, Kristopher P Fennie & Ann B Williams. (2010) Effects of nurse‐delivered home visits combined with telephone calls on medication adherence and quality of life in HIV‐infected heroin users in Hunan of China. Journal of Clinical Nursing 19:3-4, pages 380-388.
Crossref
Crossref
Andrea Krüsi, Evan Wood, Julio Montaner & Thomas Kerr. (2010) Social and structural determinants of HAART access and adherence among injection drug users. International Journal of Drug Policy 21:1, pages 4-9.
Crossref
Crossref
Liza McCoy. (2009) Time, self and the medication day: a closer look at the everyday work of ‘adherence’. Sociology of Health & Illness 31:1, pages 128-146.
Crossref
Crossref
Stephen J. Ferrando & Todd Loftus. 2008. The Spectrum of Neuro-AIDS Disorders. The Spectrum of Neuro-AIDS Disorders
393
410
.
Evan Wood, Thomas Kerr, Mark W Tyndall & Julio SG Montaner. (2008) A review of barriers and facilitators of HIV treatment among injection drug users. AIDS 22:11, pages 1247-1256.
Crossref
Crossref
Mark J. Ferris, Charles F. Mactutus & Rosemarie M. Booze. (2008) Neurotoxic profiles of HIV, psychostimulant drugs of abuse, and their concerted effect on the brain: Current status of dopamine system vulnerability in NeuroAIDS. Neuroscience & Biobehavioral Reviews 32:5, pages 883-909.
Crossref
Crossref
Conall O’Cleirigh, Gail Ironson & Jasper A.J. Smits. (2007) Does Distress Tolerance Moderate the Impact of Major Life Events on Psychosocial Variables and Behaviors Important in the Management of HIV?. Behavior Therapy 38:3, pages 314-323.
Crossref
Crossref
Natalia Bobrova, Anya Sarang, Raminta Stuikyte & Konstantin Lezhentsev. (2007) Obstacles in provision of anti-retroviral treatment to drug users in Central and Eastern Europe and Central Asia: A regional overview. International Journal of Drug Policy 18:4, pages 313-318.
Crossref
Crossref
Harout K Tossonian, Jesse D Raffa, Jason Grebely, Brendon Trotter, Mark Viljoen, Annabel Mead, Milan Khara, Mark McLean, Fiona Duncan, Chris Fraser, Stanley DeVlaming & Brian Conway. (2007) Methadone Dosing Strategies in HIV-Infected Injection Drug Users Enrolled in a Directly Observed Therapy Program. JAIDS Journal of Acquired Immune Deficiency Syndromes 45:3, pages 324-327.
Crossref
Crossref
Debra A. MurphyWilliam D. Marelich, Neil B. Rappaport, Dannie Hoffman & Charles Farthing. (2016) Results of an Antiretroviral Adherence Intervention: STAR (Staying Healthy: Taking Antiretrovirals Regularly). Journal of the International Association of Physicians in AIDS Care 6:2, pages 113-124.
Crossref
Crossref
Michael Alan Horberg, Leo Bartemeier Hurley, Michael Jonah Silverberg, C James Kinsman & Charles Patrick Quesenberry. (2007) Effect of Clinical Pharmacists on Utilization of and Clinical Response to Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes 44:5, pages 531-539.
Crossref
Crossref
Carla J. Berg, Susan E. Michelson & Steven A. Safren. (2007) Behavioral Aspects of HIV Care: Adherence, Depression, Substance Use, and HIV-Transmission Behaviors. Infectious Disease Clinics of North America 21:1, pages 181-200.
Crossref
Crossref
Lynn E. Sullivan, Declan Barry, Brent A. Moore, Marek C. Chawarski, Jeanette M. Tetrault, Michael V. Pantalon, Patrick G. O'Connor, Richard S. Schottenfeld & David A. Fiellin. (2006) A Trial of Integrated Buprenorphine/Naloxone and HIV Clinical Care. Clinical Infectious Diseases 43:Supplement_4, pages S184-S190.
Crossref
Crossref
Nancy A. Haug, James L. Sorensen, Valerie A. Gruber, Nicole Lollo & Gregory Roth. (2016) HAART Adherence Strategies for Methadone Clients Who Are HIV-Positive. Behavior Modification 30:6, pages 752-781.
Crossref
Crossref
Sergio Rueda, Laura Y. Park-Wyllie, Ahmed Bayoumi, Anne-Marie Tynan, Tony Antoniou, Sean Rourke & Richard Glazier. (2006) Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS. Cochrane Database of Systematic Reviews.
Crossref
Crossref
N. Machouf & R.-G. Lalonde. (2006) La thérapie sous observation directe (DOT): de la tuberculose au VIH. Revue d'Épidémiologie et de Santé Publique 54:1, pages 73-89.
Crossref
Crossref
Geetanjali Chander, Seth Himelhoch & Richard D Moore. (2006) Substance Abuse and Psychiatric Disorders in HIV-Positive Patients. Drugs 66:6, pages 769-789.
Crossref
Crossref
Joel Milam, Jean L Richardson, Allen McCutchan, Susan Stoyanoff, Jony Weiss, Carol Kemper, Robert A Larsen, Harry Hollander, Penny Weismuller & Robert Bolan. (2005) Effect of a Brief Antiretroviral Adherence Intervention Delivered by HIV Care Providers. JAIDS Journal of Acquired Immune Deficiency Syndromes 40:3, pages 356-363.
Crossref
Crossref
Gail Ironson, Conall O’Cleirigh, Mary Ann Fletcher, Jean Philippe Laurenceau, Elizabeth Balbin, Nancy Klimas, Neil Schneiderman & George Solomon. (2005) Psychosocial Factors Predict CD4 and Viral Load Change in Men and Women With Human Immunodeficiency Virus in the Era of Highly Active Antiretroviral Treatment. Psychosomatic Medicine 67:6, pages 1013-1021.
Crossref
Crossref
Evan Wood, Robert S Hogg, P Richard Harrigan & Julio SG Montaner. (2005) When to initiate antiretroviral therapy in HIV-1-infected adults: a review for clinicians and patients. The Lancet Infectious Diseases 5:7, pages 407-414.
Crossref
Crossref
Evan Wood, Robert S Hogg, Thomas Kerr, Anita Palepu, Ruth Zhang & Julio SG Montaner. (2005) Impact of accessing methadone on the time to initiating HIV treatment among antiretroviral-naive HIV-infected injection drug users. AIDS 19:8, pages 837-839.
Crossref
Crossref
A. R. Moss, J. A. Hahn, S. Perry, E. D. Charlebois, D. Guzman, R. A. Clark & D. R. Bangsberg. (2004) Adherence to Highly Active Antiretroviral Therapy in the Homeless Population in San Francisco: A Prospective Study. Clinical Infectious Diseases 39:8, pages 1190-1198.
Crossref
Crossref
Joan S. Tucker, Maria Orlando, M. Audrey Burnam, Cathy D. Sherbourne, Fuan-Yue Kung & Allen L. Gifford. (2004) Psychosocial Mediators of Antiretroviral Nonadherence in HIV-Positive Adults With Substance Use and Mental Health Problems.. Health Psychology 23:4, pages 363-370.
Crossref
Crossref
Brian Conway, Jennie Prasad, Robert Reynolds, John Farley, Michelle Jones, Salima Jutha, Nadine Smith, Annabel Mead & Stanley DeVlaming. (2004) Directly Observed Therapy for the Management of HIV-Infected Patients in a Methadone Program. Clinical Infectious Diseases 38:Supplement_5, pages S402-S408.
Crossref
Crossref
Grace E. Macalino, Jennifer A. Mitty, Lauri B. Bazerman, Kavita Singh, Michelle McKenzie & Timothy Flanigan. (2004) Modified Directly Observed Therapy for the Treatment of HIV-Seropositive Substance Users: Lessons Learned from a Pilot Study. Clinical Infectious Diseases 38:Supplement_5, pages S393-S397.
Crossref
Crossref
Thomas Kerr, Anita Palepu, Gordon Barnes, John Walsh, Robert Hogg, Julio Montaner, Mark Tyndall & Evan Wood. (2003) Psychosocial Determinants of Adherence to Highly Active Antiretroviral Therapy among Injection Drug Users in Vancouver. Antiviral Therapy 9:3, pages 407-414.
Crossref
Crossref
Maithe Enriquez, Nancy R. Lackey, Mary C. O'Connor & David S. McKinsey. (2004) Successful adherence after multiple HIV treatment failures. Journal of Advanced Nursing 45:4, pages 438-446.
Crossref
Crossref
Maithe Enriquez, Paul A. GoreJr.Jr., Mary C. O'Connor & David S. McKinsey. (2004) Assessment of Readiness for Adherence by HIV-Positive Males Who Had Previously Failed Treatment. Journal of the Association of Nurses in AIDS care 15:1, pages 42-49.
Crossref
Crossref
Mallory O. Johnson, Sheryl L. Catz, Robert H. Remien, Mary Jane Rotheram-Borus, Stephen F. Morin, Edwin Charlebois, Cheryl Gore-Felton, Rise B. Goldsten, Hannah Wolfe, Marguerita Lightfoot, Margaret A. Chesney & The NIMH Healthy Living Project Tea. (2003) Theory-Guided, Empirically Supported Avenues for Intervention on HIV Medication Nonadherence: Findings from the Healthy Living Project. AIDS Patient Care and STDs 17:12, pages 645-656.
Crossref
Crossref
Pilar Ramírez García & José K. Côté. (2003) Factors Affecting Adherence to Antiretroviral Therapy in People Living with HIV/AIDS. Journal of the Association of Nurses in AIDS care 14:4, pages 37-45.
Crossref
Crossref
D. A. Wohl, B. L. Stephenson, C. E. Golin, C. Nichole Kiziah, D. Rosen, B. Ngo, H. Liu & A. H. Kaplan. (2003) Adherence to Directly Observed Antiretroviral Therapy among Human Immunodeficiency Virus--Infected Prison Inmates. Clinical Infectious Diseases 36:12, pages 1572-1576.
Crossref
Crossref
Joan S Tucker, M.Audrey Burnam, Cathy D Sherbourne, Fuan-Yue Kung & Allen L Gifford. (2003) Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. The American Journal of Medicine 114:7, pages 573-580.
Crossref
Crossref
Albert Tuldrà & Albert W. Wu. (2002) Interventions to Improve Adherence to Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes 31, pages S154-S157.
Crossref
Crossref
Jennifer Adelson Mitty, Valerie E. Stone, Michael Sands, Grace Macalino & Timothy Flanigan. (2002) Directly Observed Therapy for the Treatment of People with Human Immunodeficiency Virus Infection: A Work in Progress. Clinical Infectious Diseases 34:7, pages 984-990.
Crossref
Crossref
Linda Fogarty, Debra Roter, Susan Larson, Jessica Burke, Jeanne Gillespie & Richard Levy. (2002) Patient adherence to HIV medication regimens: a review of published and abstract reports. Patient Education and Counseling 46:2, pages 93-108.
Crossref
Crossref
Jenny Petrak & David Miller. 2001. The Psychology of Sexual Health. The Psychology of Sexual Health
141
161
.
Valerie E. Stone. (2001) Strategies for Optimizing Adherence to Highly Active Antiretroviral Therapy: Lessons from Research and Clinical Practice. Clinical Infectious Diseases 33:6, pages 865-872.
Crossref
Crossref
Cyril Tarquinio & Gustave Nicolas Fischer. (2001) Therapeutic compliance methodologies in HIV-infection treatment: A comparative study. Swiss Journal of Psychology 60:3, pages 136-160.
Crossref
Crossref
Brian R. Edlin, Karen H. Seal, Jennifer Lorvick, Alex H. Kral, Daniel H. Ciccarone, Lisa D. Moore & Bernard Lo. (2001) Is It Justifiable to Withhold Treatment for Hepatitis C from Illicit-Drug Users?. New England Journal of Medicine 345:3, pages 211-214.
Crossref
Crossref
David R Bangsberg, Linda M Mundy & Jacqueline P Tulsky. (2001) Expanding directly observed therapy: tuberculosis to human immunodeficiency virus. The American Journal of Medicine 110:8, pages 664-666.
Crossref
Crossref
S. Kelly Avants, Arthur Margolin, Lara A. Warburton, Keith A. Hawkins & Julia Shi. (2010) Predictors of Nonadherence to HIV‐Related Medication Regimens During Methadone Stabilization. The American Journal on Addictions 10:1, pages 69-78.
Crossref
Crossref
G. Pérez domínguez, M. Torrens & R. Martín-santos. (2001) Adhesión al tratamiento antirretroviral en pacientes toxicómanos con infección por el VIH. Trastornos Adictivos 3:1, pages 43-50.
Crossref
Crossref
Albert Tuldrà, Carmina R Fumaz, Ma José Ferrer, Ramon Bayés, Albert Arnó, Montserrat Balagué, Anna Bonjoch, Antoni Jou, Eugènia Negredo, Roger Paredes, Lidia Ruiz, Joan Romeu, Guillem Sirera, Cristina Tural, David Burger & Bonaventura Clotet. (2000) Prospective Randomized Two-Arm Controlled Study To Determine the Efficacy of a Specific Intervention To Improve Long-Term Adherence to Highly Active Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes 25:3, pages 221-228.
Crossref
Crossref
Albert Tuldr??Carmina R Fumaz, Ma Jos?? Ferrer, Ramon Bay??s, Albert Arn??Montserrat Balagu??Anna Bonjoch, Antoni Jou, Eug??nia Negredo, Roger Paredes, Lidia Ruiz, Joan Romeu, Guillem Sirera, Cristina Tural, David Burger & Bonaventura Clotet. (2000) Prospective Randomized Two-Arm Controlled Study To Determine the Efficacy of a Specific Intervention To Improve Long-Term Adherence to Highly Active Antiretroviral Therapy. Journal of Acquired Immune Deficiency Syndromes, pages 221-228.
Crossref
Crossref
M Haddad, C Inch, RH Glazier, AL Wilkins, A Bayoumi & S Rourke. 1996. The Cochrane Database of Systematic Reviews. The Cochrane Database of Systematic Reviews.
M.P Carrieri, D Vlahov, P Dellamonica, H Gallais, G Lepeu, B Spire & Y Obadia. (2000) Use of buprenorphine in HIV-infected injection drug users: negligible impact on virologic response to HAART. Drug and Alcohol Dependence 60:1, pages 51-54.
Crossref
Crossref
J. P. Moatti, M. P. Carrieri, B. Spire, J. A. Gastaut, J. P. Cassuto & J. Moreau. (2000) Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatment. AIDS 14:2, pages 151-155.
Crossref
Crossref